全文获取类型
收费全文 | 1280959篇 |
免费 | 100307篇 |
国内免费 | 2278篇 |
专业分类
耳鼻咽喉 | 18458篇 |
儿科学 | 44383篇 |
妇产科学 | 35035篇 |
基础医学 | 182670篇 |
口腔科学 | 33635篇 |
临床医学 | 111785篇 |
内科学 | 258713篇 |
皮肤病学 | 28085篇 |
神经病学 | 100562篇 |
特种医学 | 51343篇 |
外国民族医学 | 660篇 |
外科学 | 196996篇 |
综合类 | 27973篇 |
现状与发展 | 1篇 |
一般理论 | 377篇 |
预防医学 | 95913篇 |
眼科学 | 28010篇 |
药学 | 95340篇 |
3篇 | |
中国医学 | 2732篇 |
肿瘤学 | 70870篇 |
出版年
2018年 | 13302篇 |
2017年 | 10125篇 |
2016年 | 11058篇 |
2015年 | 12609篇 |
2014年 | 17429篇 |
2013年 | 26498篇 |
2012年 | 36404篇 |
2011年 | 38429篇 |
2010年 | 23040篇 |
2009年 | 22002篇 |
2008年 | 36888篇 |
2007年 | 39556篇 |
2006年 | 39782篇 |
2005年 | 38720篇 |
2004年 | 37774篇 |
2003年 | 36635篇 |
2002年 | 35944篇 |
2001年 | 64103篇 |
2000年 | 66619篇 |
1999年 | 56517篇 |
1998年 | 15200篇 |
1997年 | 13823篇 |
1996年 | 14256篇 |
1995年 | 13517篇 |
1994年 | 12812篇 |
1993年 | 11813篇 |
1992年 | 44582篇 |
1991年 | 43497篇 |
1990年 | 42241篇 |
1989年 | 40142篇 |
1988年 | 36915篇 |
1987年 | 36249篇 |
1986年 | 33639篇 |
1985年 | 32283篇 |
1984年 | 24145篇 |
1983年 | 20271篇 |
1982年 | 11726篇 |
1981年 | 10695篇 |
1980年 | 9516篇 |
1979年 | 21341篇 |
1978年 | 14822篇 |
1977年 | 12535篇 |
1976年 | 11694篇 |
1975年 | 12624篇 |
1974年 | 14662篇 |
1973年 | 14120篇 |
1972年 | 12945篇 |
1971年 | 11732篇 |
1970年 | 11050篇 |
1969年 | 10027篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
目的 通过网络药理学的方法进行预测,再深一步进行动物实验验证来研究柴胡疏肝散治疗CAG的作用机制。方法 首先在TCMSP数据库中检索柴胡疏肝散的所有活性成分与药物靶点;通过收集PharmGkb、OMIM、GeneCards和DrugBank数据库中收录的慢性萎缩性胃炎的相关靶点。将药物靶点与疾病靶点进行映射筛选出交集靶点,将得到的交集靶点构建PPI网络与活性成分-共同靶点网络,并对其进行GO和KEGG富集分析。最后利用Vina软件进行分子对接实验验证,并通过免疫印迹法验证柴胡疏肝散对两种受体蛋白EGFR和STAT1的影响。结果 最终筛选得到柴胡疏肝散活性成分104个,潜在靶点238个,与慢性萎缩性胃炎的交集靶点52个;GO与KEGG富集分析分别得到2166条目和148条目,主要涉及到JAK-STAT信号通路、TNF信号通路、HIF-1信号通路等;分子对接结果显示EGFR、STAT1两个靶点能够与核心活性成分能够自发结合成较为稳定的构像;免疫印迹法实验证明柴胡疏肝散能够降低大鼠胃黏膜组织EGFR和STAT1蛋白表达。结论 通过网络药理学和实验验证,发现柴胡疏肝散可能通过调节EGFR和STAT1蛋白表达来共同调控胃黏膜细胞增殖与凋亡,进而发挥着治疗慢性萎缩性胃炎的效果,为深入进行柴胡疏肝散治疗慢性萎缩性胃炎的作用机制研究提供新思路和新方法。 相似文献
2.
Molnár B. Aroca S. Dobos A. Orbán K. Szabó J. Windisch P. Stähli A. Sculean A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with... 相似文献
3.
4.
5.
6.
7.
8.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
9.
A Coupled FEM-BEM Approach for the Solution of the Free-Boundary Axi-Symmetric Plasma Equilibrium Problem 下载免费PDF全文
M. Bonotto D. Abate P. Bettini & F. Villone 《Communications In Computational Physics》2022,31(1):27-59
In this paper we present a coupled Finite Element Method – Boundary Element Method (FEM-BEM) approach for the solution of the free-boundary axi-symmetric
plasma equilibrium problem. The proposed method, obtained from an improvement
of the Hagenow-Lackner coupling method, allows to efficiently model the equilibrium
problem in unbounded domains by discretizing only the plasma region; the external
conductors can be modelled either as 2D or 3D models, according to the problem of interest. The paper explores different iterative methods for the solution of the nonlinear
Grad-Shafranov equation, such as Picard, Newton-Raphson and Newton-Krylov, in order to provide a robust and reliable tool, able to handle large-scale problems (e.g. high
resolution equilibria). This method has been implemented in the FRIDA code (FRee-boundary Integro-Differential Axisimmetric – https://github.
om/matteobonotto/
FRIDA), together with a suitable Adaptive Integration Technique (AIT) for the computation of the source term. FRIDA has been successfully tested and validated against
experimental data from RFX-mod device, and numerical equilibria of an ITER-like device. 相似文献
10.
Clinical & Experimental Metastasis - 相似文献